Evidence map›Paper›PMID 39263862›Full record

ArticleBiology open2024

A larval zebrafish model of cardiac physiological recovery following cardiac arrest and myocardial hypoxic damage.

Warren Burggren, Regina Abramova, Naim M Bautista, Regina Fritsche Danielson, Ben Dubansky, Avi Gupta, Kenny Hansson, Neha Iyer, Pudur Jagadeeswaran, Karin Jennbacken and 7 more

Abstract read
In one paragraph

Article in Biology open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Warren BurggrenDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.ORCID 0000-0001-8023-420X
Regina AbramovaDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.
Naim M BautistaDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.ORCID 0000-0003-0634-0842
Regina Fritsche DanielsonSVP and head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 50, Sweden.ORCID 0000-0003-0582-6429
Ben DubanskyDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.ORCID 0000-0003-4584-1690
Avi GuptaDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.
Kenny HanssonBioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 50, Sweden.ORCID 0000-0003-0448-5140
Neha IyerDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.ORCID 0000-0002-8367-489X
Pudur JagadeeswaranDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.ORCID 0000-0001-8892-4969
Karin JennbackenBioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 50, Sweden.ORCID 0000-0003-1254-5158
Katarina Rydén-MarkinhuthaBioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 50, Sweden.
Vishal PatelDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.
Revathi RamanDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.ORCID 0000-0003-2010-6171
Hersh TrivediDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.
Karem Vazquez RomanDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.ORCID 0000-0002-1553-0544
Steven WilliamsDevelopmental Integrative Biology Research Group, Department of Biological Sciences, University of North Texas, Denton, TX 76205, USA.
Qing-Dong WangBioscience Cardiovascular, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg 431 50, Sweden.ORCID 0000-0001-9570-4411

Funding

G-RISE at the University of North TexasT32GM136501 · NIGMS · UNIVERSITY OF NORTH TEXAS · PI BURGGREN, WARREN, HUGHES, LEE · 2021 to 2024
$1.8M
AstraZenecaNIGMS NIH HHS T32 GM136501University of North Texas
6 · The paper itself

Abstract

Contemporary cardiac injury models in zebrafish larvae include cryoinjury, laser ablation, pharmacological treatment and cardiac dysfunction mutations. Although effective in damaging cardiomyocytes, these models lack the important element of myocardial hypoxia, which induces critical molecular cascades within cardiac muscle. We have developed a novel, tractable, high throughput in vivo model of hypoxia-induced cardiac damage that can subsequently be used in screening cardioactive drugs and testing recovery therapies. Our potentially more realistic model for studying cardiac arrest and recovery involves larval zebrafish (Danio rerio) acutely exposed to severe hypoxia (PO2=5-7 mmHg). Such exposure induces loss of mobility quickly followed by cardiac arrest occurring within 120 min in 5 days post fertilization (dpf) and within 40 min at 10 dpf. Approximately 90% of 5 dpf larvae survive acute hypoxic exposure, but survival fell to 30% by 10 dpf. Upon return to air-saturated water, only a subset of larvae resumed heartbeat, occurring within 4 min (5 dpf) and 6-8 min (8-10 dpf). Heart rate, stroke volume and cardiac output in control larvae before hypoxic exposure were 188±5 bpm, 0.20±0.001 nL and 35.5±2.2 nL/min (n=35), respectively. After briefly falling to zero upon severe hypoxic exposure, heart rate returned to control values by 24 h of recovery. However, reflecting the severe cardiac damage induced by the hypoxic episode, stroke volume and cardiac output remained depressed by ∼50% from control values at 24 h of recovery, and full restoration of cardiac function ultimately required 72 h post-cardiac arrest. Immunohistological staining showed co-localization of Troponin C (identifying cardiomyocytes) and Capase-3 (identifying cellular apoptosis). As an alternative to models employing mechanical or pharmacological damage to the developing myocardium, the highly reproducible cardiac effects of acute hypoxia-induced cardiac arrest in the larval zebrafish represent an alternative, potentially more realistic model that mimics the cellular and molecular consequences of an infarction for studying cardiac tissue hypoxia injury and recovery of function.

Indexed as

Disease Models, AnimalHeart ArrestHypoxiaLarvaZebrafishAnimalsHeartHeart RateMyocardiumAnimal modelCardiac outputHypoxiaMyocardial infarctionRecoveryRegenerationZebrafish

Identifiers

PMID39263862
PMCPMC11413934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.